Live news related to AMOEBA stock (FR0011051598): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on AMOEBA mainly cover M&A activity, the dividend and payout policy et analyst notes. The stock trades at €0,87 on Euronext Paris, up 1,52% at the last update. This page lists the articles published on AMOEBA stock to track the share price, company announcements and any item likely to influence market perception.
Amoéba's stock increases by 3.42% to €0.91 in mid-morning trading, going against the grain of a CAC 40 that is down by 0.89% at 8128.87 points. The bi…
Amoéba and its partner Koppert have obtained two large-scale experimental authorizations in the Netherlands for the biofungicide AXPERA, lasting two y…
Amoéba announces the emergency market authorization for its biocontrol product AXPERA, valid for 120 days, to combat vine downy mildew in France. This…
Amoéba (FR0011051598 - ALMIB) announces that it has conducted a comprehensive field testing program in Brazil, in partnership with Koppert, to evaluat…
Amoéba has announced the successful completion of its capital increase through a private placement, raising €6.67 million from institutional investors…
Amoéba announces the holding of its Ordinary and Extraordinary General Meeting on April 3, 2026. This summons comes in a context where the greentech c…
Amoéba has received its first order from Koppert, the global leader in biocontrol, as part of the distribution agreement signed in June 2025. This ord…
Amoeba stock has significantly advanced this Thursday morning, trading at 1.008 euros, marking a 3.7% increase from the previous day. The stock of the…
Greentech company Amoéba has released its 2025 annual results, showing an increasing operational deficit of 6.8 million euros compared to 5.7 million …
Amoéba announces that ANSES has initiated the final phase of the evaluation of its biocontrol product AXPERA, submitted in March 2025. Concurrently, F…
